bpc-157 human clinical trial tendon injury randomized Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review What no one's telling you
Description
5:4478 doi: 10.1038/ncomms5478 (2014)
This makes it a potentially safer alternative for metabolic support compared to hGH itself

Joint cartilage has limited blood supply, and enhanced vascularity in the surrounding synovium and subchondral bone can improve nutrient delivery to damaged joint structures Anti-inflammatory modulation: BPC-157 modulates the nitric oxide system and reduces pro-inflammatory cytokines that drive arthritis progression Growth factor stimulation: The peptide upregulates vascular endothelial growth factor (VEGF) and growth hormone receptors, creating a more favorable environment for tissue repair Connective tissue healing: Research on tendons and ligaments demonstrates BPC-157's ability to accelerate healing in collagen-rich connective tissues, which are integral to joint structure Pain reduction: Through its anti-inflammatory and healing effects, BPC-157 may reduce joint pain at the source rather than simply masking it For detailed information on how BPC-157 supports tendon repair specifically, see our guide on peptides for tendon repair

Royal Soc

Cartilage and joint repair models: Intraarticular injection of AOD9604 in a collagenase induced rabbit osteoarthritis model showed improved cartilage architecture and regeneration

This could possibly be carried out given its special interaction and modulatory effects with the nitric oxide (NO) system [43,44,45,77,78,79,80,81], thrombocytes [81,82,83], and many molecular pathways [36,37,43,44,45,46,47,48,49,50,51], particularly NO molecular pathways [43,44,45], which is a point also noticed in myotendinous junction recovery [13]
